Wikidata

(Q39959029)

English

A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration

scientific article

In more languages

Statements

title
A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19643495
retrieved
15 September 2017
author name string
David S Boyer
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19643495
retrieved
15 September 2017
Jeffrey S Heier
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19643495
retrieved
15 September 2017
David M Brown
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
19643495
retrieved
15 September 2017
Steven F Francom
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
19643495
retrieved
15 September 2017
Tsontcho Ianchulev
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
19643495
retrieved
15 September 2017
Roman G Rubio
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
19643495
retrieved
15 September 2017
publication date
29 July 2009
1 reference
stated in
Europe PubMed Central
PubMed ID
19643495
retrieved
15 September 2017
page(s)
1731-1739
1 reference
stated in
Europe PubMed Central
PubMed ID
19643495
retrieved
15 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39959029&oldid=1881263066"